Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 22.11% is 39% below its 5-year average of 35.95%, near the low end of its 5-year range (22.11%–48.62%).
As of the fiscal period ended Tuesday, June 30, 2026. 19.27% below its 12-month average of 27.39%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 22.11%.
DEBT TO ASSETS RATIO
22.11%
DEBT TO ASSETS RATIO AVG TTM
27.39%
DEBT TO ASSETS RATIO AVG 3Y
33.96%
DEBT TO ASSETS RATIO AVG 5Y
35.95%
DEBT TO ASSETS RATIO AVG 10Y
40.72%
DEBT TO ASSETS RATIO AVG 15Y
37.22%
DEBT TO ASSETS RATIO AVG 20Y
28.23%
CURRENT VS TTM AVG
-19.27%
CURRENT VS 3Y AVG
-34.90%
CURRENT VS 5Y AVG
-38.50%
CURRENT VS 10Y AVG
-45.70%
CURRENT VS 15Y AVG
-40.60%
CURRENT VS 20Y AVG
-21.69%
SECTOR MEDIAN · HEALTHCARE
0.13%
median of 386 covered companies
CURRENT VS SECTOR MEDIAN
+16907.17%
vs the sector median at left
ANI Pharmaceuticals, Inc.
Market Cap
$1.65B
Debt to Assets Ratio
22.11%
TTM Avg
27.39%
3Y Avg
33.96%
5Y Avg
35.95%
Market Cap
$1.65B
Debt to Assets Ratio
0.76%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.71B
Debt to Assets Ratio
0.44%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.76B
Debt to Assets Ratio
0.26%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.52B
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.78B
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.78B
Debt to Assets Ratio
0.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ANI Pharmaceuticals, Inc. (ANIP) | $1.65B | 22.11% | 27.39% | 33.96% | 35.95% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | 0.76% | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 0.44% | N/A | N/A | N/A |
| Certara, Inc. (CERT)vs › | $1.57B | 0.21% | N/A | N/A | N/A |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | 0.26% | N/A | N/A | N/A |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 0.25% | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.52B | 0.00% | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | 0.09% | N/A | N/A | N/A |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | 0.11% | N/A | N/A | N/A |
| Braveheart Bio, Inc. (BRVE)vs › | $1.51B | N/A | N/A | N/A | N/A |
Debt/Assets
22.1%
Debt/Equity
0.55
Current Ratio
2.91
Interest Coverage
4.0x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 22.11% |
| 2026-03-31 | 23.05% |
| 2025-12-31 | 22.58% |
| 2025-09-30 | 22.91% |
| 2025-06-30 | 46.28% |
| 2025-03-31 | 48.19% |
| 2024-12-31 | 48.62% |
| 2024-09-30 | 48.58% |
| 2024-06-30 | 30.98% |
| 2024-03-31 | 31.21% |
| 2023-12-31 | 31.59% |
| 2023-09-30 | 32.12% |
| 2023-06-30 | 33.29% |
| 2023-03-31 | 37.41% |
| 2022-12-31 | 37.70% |
| 2022-09-30 | 38.79% |
| 2022-06-30 | 38.19% |
| 2022-03-31 | 38.55% |
| 2021-12-31 | 37.24% |
| 2021-09-30 | 42.94% |
| 2021-06-30 | 42.63% |
| 2021-03-31 | 39.54% |
| 2020-12-31 | 40.26% |
| 2020-09-30 | 40.63% |
| 2020-06-30 | 40.87% |
| 2020-03-31 | 41.47% |
| 2019-12-31 | 40.66% |
| 2019-09-30 | 40.85% |
| 2019-06-30 | 41.55% |
| 2019-03-31 | 42.33% |
| 2018-12-31 | 42.50% |
| 2018-09-30 | 46.82% |
| 2018-06-30 | 48.24% |
| 2018-03-31 | 48.45% |
| 2017-12-31 | 48.89% |
| 2017-09-30 | 40.84% |
| 2017-06-30 | 42.98% |
| 2017-03-31 | 42.70% |
| 2016-12-31 | 37.37% |
| 2016-09-30 | 37.20% |
| 2016-06-30 | 37.98% |
| 2016-03-31 | 39.51% |
| 2015-12-31 | 39.76% |
| 2015-09-30 | 40.66% |
| 2015-06-30 | 42.08% |
| 2015-03-31 | 42.17% |
| 2014-12-31 | 41.97% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 23.11% |
| 2012-12-31 | 20.34% |
| 2012-09-30 | 17.57% |
| 2012-06-30 | 22.15% |
| 2012-03-31 | 19.23% |
| 2011-12-31 | 27.79% |
| 2011-09-30 | 27.34% |
| 2011-06-30 | 46.19% |
| 2011-03-31 | 33.78% |
| 2010-12-31 | 41.43% |
| 2010-09-30 | 45.05% |
| 2010-06-30 | 35.66% |
| 2010-03-31 | 38.22% |
| 2009-12-31 | 45.77% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 579.27% |
